Compare CPF & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CPF | INMD |
|---|---|---|
| Founded | 1954 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 849.9M | 879.2M |
| IPO Year | N/A | 2019 |
| Metric | CPF | INMD |
|---|---|---|
| Price | $31.97 | $14.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 6 |
| Target Price | ★ $34.50 | $17.00 |
| AVG Volume (30 Days) | 121.9K | ★ 552.9K |
| Earning Date | 01-28-2026 | 11-05-2025 |
| Dividend Yield | ★ 3.48% | N/A |
| EPS Growth | 15.70 | ★ 20.42 |
| EPS | ★ 2.43 | 2.21 |
| Revenue | $260,672,000.00 | ★ $364,494,000.00 |
| Revenue This Year | $1.70 | N/A |
| Revenue Next Year | $7.10 | $3.76 |
| P/E Ratio | $13.23 | ★ $6.56 |
| Revenue Growth | ★ 6.55 | N/A |
| 52 Week Low | $23.16 | $13.14 |
| 52 Week High | $32.23 | $19.78 |
| Indicator | CPF | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 68.97 | 52.56 |
| Support Level | $29.92 | $14.24 |
| Resistance Level | $31.04 | $14.63 |
| Average True Range (ATR) | 0.77 | 0.30 |
| MACD | 0.19 | 0.07 |
| Stochastic Oscillator | 92.18 | 87.98 |
Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.